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Round table discussion
Diagnosis of fetal lung maturity and antenatal treatment
Moderator: Uwe Lorenz
The first round table discussion covered the fol-
lowing main topics:
1. Indications for amniocentesis to determine an-
tepartum lung maturity
2. Upper and lower gestational age limits for glu-
cocorticoid treatment
Alternatives to glucocorticoid treatment
3. Management of premature rupture of the am-
nion
Topic 1
There is an increasing tendency not to perform
amniocentesis for determination of antepartum
lung maturity despite the fact that it is thought to
involve little risk under ultrasonic control. Most
of the clinics represented continue to sample amni-
otic fluid for determination of lung maturity only
in diabetic mothers and in cases of severe toxemia
(DUDENHAUSEN). SCHELLENBERG samples only in
diabetics but not in cases of preeclampsia, be-
cause here the clinical situation usually does not
permit a longer waiting period. Amniocentesis for
determination of lung maturity are now seldom
performed at the Glasgow Gynecological Hospital
as well (WHITTLE). As pointed out by ENHORNING,
improved ultrasonic biometry now provides for a
much better estimation of fetus size.
Topic 2
Opinions differ widely as to whether glucocorti-
coid therapy is of any value at all: advocates of
glucocorticoid therapy (SCHELLENBERG, LORENZ,
DUDENHAUSEN) consider it useful to start treat-
ment between the 26th and 34th week of preg-
nancy. Beyond the 34th week of pregnancy, no
attempt is made to delay birth; prior to that, a
tocolysis is carried out for 48 hours with concom-
itant initiation of corticoid therapy. An indication
for corticoid treatment is seldom seen in Scandina-
via (HALLMAN) as well as in Cambridge (MORLEY).
Here corticoids have only been given to 9% of
the mothers of children born before the 30th week
of pregnancy. As SCHELLENBERG points out, ther-
apeutic results with corticoids are not very good
prior to the 30th week of pregnancy. Concerning
the lower treatment limit, OBLADEN argues that,
in cases where a fetus is classified as viable and
active neonatal intensive care measures are initi-
ated by the pediatrician in the delivery room im-
mediately after birth, the child must also be given
the chance of prenatal therapy, even though the
effect of corticoids is considered negligible prior
to the 30th week of pregnancy. According to
SCHELLENBERG, particularly boys profit at a low
gestational age (before the 30th week of preg-
nancy) at the Auckland Clinic. BALLARD likewise
found more favorable survival data after corticoid
treatment in the weight group of 750—1000 g,
thus corresponding to about the 27th week of
pregnancy. As long as controlled studies are lack-
ing on the results in extremely underweight chil-
dren, SCHELLENBERG would apply corticoids in all
cases where there are no contraindications. The
first results of a combination therapy consisting
of glucocorticoids plus TRH can be expected from
Auckland around mid-1987.
Alternatives to glucocorticoid treatment: DUDEN-
HAUSEN offers ambroxol as well as thyroxine, in-
tra-amniotically applied. SCHELLENBERG sees no
advantages in ambroxol as compared to glucocor-
ticoids but rather a disadvantage in its long appli-
cation period (5 days). He considers the range
of indications for ambroxol to be very narrowly
limited and believes it may perhaps be given to
diabetic mothers. Results of a combination ther-
apy with glucocorticoids, triiodothyronine and
prolactin carried out by the Auckland study group
are not yet ready for publication.
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^ incipient intrauterine infection. DUDENHAUSEN
Concerning the management of premature rup- performs tocolysis in patients prior to the 35th
ture of membranes, LORENZ points out that va- week of pregnancy, provided they show no signs
rious schools exist, the treatment tactics of some of inflammation, and applies glucocorticoids
being tocolysis alone and of others tocolysis + (down to the 24th week of pregnancy). After the
antibiotics + glucocorticoids, while still others 35th week of pregnancy, an active procedure is
apply no therapy at all. WHITTLE does not perform adopted. SCHELLENBERG likewise performs toco-
tocolysis or give corticoids on premature rupture lysis and applies glucocorticoids up to the 34th
of membranes. He regards the onset of labor after week of pregnancy in cases where there are no
the rupture of membranes as the result of the signs of inflammation.
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